View the Whatcom County Respiratory Virus Dashboard Here
Requested actions Be aware, the first cases of monkeypox virus (MPV) in cisgender adult females and an adolescent under the age of 18 were reported in Washington State. Clinicians should suspect Monkeypox virus infection in any patient presenting with one or more lesions that suggest monkeypox infection, regardless of the patient’s age, social history, gender, … 08/26/22 Health Advisory: Monkeypox Update for Providers
Requested actions Washington currently has 53 reported cases of monkeypox, mostly in King County. Early cases were linked to travel but Public Health Seattle–King County announced last week the virus is likely spreading locally. Monkeypox is rare and not often seen in the United States. It can cause a rash that looks like bumps, blisters … 07/18/22 Health Advisory: Updated Monkeypox Guidance
Requested actions Immediately report suspected monkeypox cases to Whatcom County Health Department. Call the reporting line: 360-778-6150. Submit a suspect monkeypox intake form to help us determine whether to test for monkeypox. Be aware, recent confirmed cases of monkeypox in the United States differ from the classic monkeypox presentation of previous outbreaks. To date, all … 06/24/22 Health Advisory: Updated Monkeypox Guidance
Be aware, Centers for Disease Control and Prevention (CDC) and Western States Scientific Safety Review Workgroup concluded COVID-19 vaccines are safe and effective for children as young as 6 months. Available to children 6 months to 4 years old: Pfizer COVID-19 vaccine, in a 3-dose primary series. Be sure to review dosage and vial labeling … 06/24/22 Health Advisory: COVID-19 Vaccine for Children as Young as 6 Months
Background On May 12, 2022, Washington State Department of Health (DOH) announced many children are behind on routine vaccinations compared to pre-pandemic levels. The report found, from June 2019 to December 2021, immunization rates dropped: ↓ 9.6% in children 19–35 months old ↓ 3.9% in children 4–6 years old ↓ 3.6% in children 11–12 years … 06/14/22 Health Advisory: Routine childhood immunization rates down
Requested actions Be aware, Centers for Disease Control and Prevention (CDC) issued a health advisory about COVID-19 rebound after Paxlovid treatment. Continue to offer Paxlovid for early-stage treatment of mild to moderate COVID-19 in people at high risk of severe disease. Be aware, providers have reported COVID-19 rebound—recurring symptoms or a new positive test after … 05/24/22 Health Advisory: COVID-19 rebound after Paxlovid treatment
Requested actions Be aware, monkeypox virus infections are occurring in non-endemic countries, including 1 case in the United States. Assess for alternative etiologies in conditions causing pox-like lesions—herpes simplex, syphilis, varicella, etc. Report suspected or confirmed monkeypox cases to the Whatcom County Health Department (WCHD). Call 360-778-6150. WCHD will coordinate testing at the public health … 05/24/22 Health Advisory: Monkeypox virus in non-endemic countries
Requested actions Be aware, the Centers for Disease Control and Prevention (CDC) and Western States Scientific Safety Review Workgroup recommend children 5-11 years should get a COVID-19 vaccine booster dose five months after completion of the primary series of the Pfizer-BioNTech vaccine. This recommendation comes after Food and Drug Administration (FDA) expanded its emergency use … 05/20/22 Health Advisory: CDC Recommends 5-11 year olds get a Pfizer COVID-19 Booster
Actions Requested Be aware of severe cases of hepatitis in children that are occurring in the U.S. and worldwide. Consider adenovirus testing in pediatric patients with hepatitis of unknown cause (see preferred samples below). Report suspect cases in children to Whatcom County Health Department. A suspect case is a child with elevated AST or ALT … 05/19/22 Health Advisory: Severe Hepatitis of Unknown Cause in Children
Requested actions Be aware, on May 5, 2022, because of the risk of thrombosis with thrombocytopenia syndrome (TTS) after getting Johnson & Johnson COVID-19 vaccine (J&J), Food and Drug Administration (FDA) limited its authorized use to people 18 years or older: For whom other COVID-19 vaccines are not accessible or clinically appropriate. Who want only … 05/16/22 Health Advisory: FDA Limits Use of Johnson & Johnson COVID-19 Vaccine.
